Cafepharma Today

June 13 2025 - Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Urogen’s bladder cancer drug wins FDA approval over adcomm’s objections
A day in the life of GSK’s U.S. president
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Agilent forges diagnostic test partnership with Pfizer; follows January deal with Eli Lilly
Yahoo/AP
Wednesday, February 13, 2013 - 10:20am
tags:
Agilent, Pfizer, Eli Lilly, cancer diagnostics, Dako
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wednesday, February 13, 2013 - 10:16am
tags:
JNJ, Multiple Myeloma, Velcade, Celgene, Revlimid, AbbVie, ONYX Pharmaceuticals, Bristol-Myers Squibb
Slow approvals put India's drug trials industry at risk
Reuters
Wednesday, February 13, 2013 - 10:14am
tags:
drug approvals, clinical trials, India
Pharmacyclics Gains ‘Breakthrough’ Status for Cancer Drug
Bloomberg
Wednesday, February 13, 2013 - 10:11am
tags:
Pharmacyclics, ibrutinib, JNJ
Promising Italian Biotech With An Upcoming CHMP Meeting
Seeking Alpha
Tuesday, February 12, 2013 - 12:25pm
tags:
CHMP, Gentium
Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg
Tuesday, February 12, 2013 - 12:13pm
tags:
Shire, Forest Labs, AstraZeneca, M&A
Dynavax Options Trade for Heplisav FDA Approval Decision
TheStreet.com
Tuesday, February 12, 2013 - 12:12pm
tags:
FDA, Dynavax, Heplisav
Alimera Sciences: A Sleeping Giant
Seeking Alpha
Tuesday, February 12, 2013 - 12:06pm
tags:
Alimera, diabetic macular edema, flucinolone ocular implant
GSK, others weigh $3-4 billion deal for Brazilian drugmaker: sources
Reuters
Tuesday, February 12, 2013 - 12:04pm
tags:
GSK, M&A, Brazil, Ache Laboratorios Farmaceuticos
Update on Lilly's Tabalumab
Yahoo/Zacks
Tuesday, February 12, 2013 - 11:12am
tags:
Eli Lilly, tabalumab, rheumatoid arthritis
Will Johnson & Johnson Win Approval for Its Diabetes Drug?
Motley Fool
Tuesday, February 12, 2013 - 11:00am
tags:
JNJ, diabetes, Invokana
Why Raptor Could Run Up To Its PDUFA
Seeking Alpha
Tuesday, February 12, 2013 - 10:59am
tags:
Raptor Pharmaceuticals, Mylan, nephropathic cystinosis, RP103
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
Tuesday, February 12, 2013 - 10:57am
tags:
patents, Celgene, myelodysplastic syndrome, Vidaza
Eli Lilly says will keep animal health business, Reuters reports
Yahoo/Fly on the Wall
Tuesday, February 12, 2013 - 10:55am
tags:
animal health, Eli Lilly, Elanco
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Yahoo/AP
Tuesday, February 12, 2013 - 10:55am
tags:
Amgen, UCB Pharmaceuticals, fractures, osteoporosis, romosozumab
Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters
Tuesday, February 12, 2013 - 10:54am
tags:
Reckitt Benckiser, Latin America, M&A, Bristol-Myers Squibb, OTC
J&J’s Marketer E-Mailed Hip Safety Concerns Before Recall
Bloomberg
Tuesday, February 12, 2013 - 10:52am
tags:
hip implants, recalls, JNJ, DePuy
U.S. court invalidates patent on Bristol hepatitis B drug
Reuters
Tuesday, February 12, 2013 - 10:46am
tags:
Bristol-Myers Squibb, hepatitis B, Baraclude, patents
Backed By Large Pharma And Key Investors, Pharmacyclics Is Set To Climb Higher
Seeking Alpha
Monday, February 11, 2013 - 11:18am
tags:
Pharmacyclics, JNJ
Endo Seen Boosted by Fidelity-Favored Sale: Real M&A
Bloomberg
Monday, February 11, 2013 - 11:14am
tags:
M&A, Endo Health Solutions, Teva, Covidien

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.